Finch Therapeutics (FNCH) - 2021 Q2 - Quarterly Report
Finch Therapeutics Finch Therapeutics (US:FNCH)2021-08-10 20:16

UNITED STATES SECURITIES AND EXCHANGE COMMISSION For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________________ to ________________ Commission File Number: 001-40227 FINCH THERAPEUTICS GROUP, INC. (Exact Name of Registrant as Specified in its Charter) Dela ...